CD19 and acute lymphoblastic leukemia: Of these 30 markers, 22 were differentially expressed in ALL cases compared to CD19+CD10+ B-cell progenitors; particularly, CD123 was markedly more expressed in the majority of cases on B-ALL blasts, compared to normal B cell progenitors [38].